MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-10-0012312
Jo Pharma Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.24 Cr
▼ 10% YoY
Net profit · FY 2025
₹2.05 Cr
Net margin 5.2%
EBITDA · FY 2025
₹4.49 Cr
EBITDA margin 11.4%
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹3.7 Cr
Issued & subscribed
Open charges
₹13.76 Cr
Satisfied ₹9.56 Cr
Company age
11 yrs
Est. 2015
Directors on board
3
As per MCA filings
About Jo Pharma Limited
Data last updated:
Jo Pharma Limited is a public limited company based in Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 12 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U23109DL2015PLC288456. Its GSTIN is 07AADCJ6242K1ZF (Delhi).
The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.7 Cr. It was formerly known as Jindal Omran Pharma Private Limited and J.O. Pharma Private Limited. It is led by directors including Rakshit Jindal and Ankit Jindal.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 7/3 Safdarjung Enclave Opposite Deer Park, Delhi, India – 110029.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.24 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.05 Cr (net margin 5.2%) and EBITDA of ₹4.49 Cr (EBITDA margin 11.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 32% over five years.
As per MCA filings, the company has open charges of ₹13.76 Cr and satisfied charges of ₹9.56 Cr on record. Court records list 12 cases involving the company, including 11 filed by the company and 1 filed against it; 4 cases are pending.
Jo Pharma Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0012312). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jopharma.com.
Company details
CIN U23109DL2015PLC288456
Registration Number 288456
Incorporation Date 12 December 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-10-0012312
Name history
Jo Pharma has undergone 2 name changes throughout its history. The company was previously known as Jindal Omran Pharma Private Limited, and J.O. Pharma Private Limited. The current legal name is Jo Pharma Limited.
| Company Name | Status |
|---|---|
| Jo Pharma Limited | Current |
| Jindal Omran Pharma Private Limited | Previous |
| J.O. Pharma Private Limited | Previous |
CIN history
Jo Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U23109DL2015PLC288456, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U23109DL2015PLC288456 | Current |
| U23109DL2015PTC288456 | Previous |
| U74900DL2015PTC288456 | Previous |
Recognitions & Rankings of Jo Pharma
Contact details
Jo Pharma Limited's registered office is in Delhi, Delhi. Its website is jopharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 7/3 Safdarjung Enclave Opposite Deer Park, Delhi, India – 110029
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Jo Pharma Limited, buy the company report.
Comprehensive company report
Jo Pharma Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Jo Pharma Limited
FY 2025 filings availableJo Pharma Limited reported revenue of ₹39.24 Cr (down 10% YoY) for FY 2025.
Revenue · FY 2025
₹39.24 Cr ▼ 10%
Net profit · FY 2025
₹2.05 Cr margin 5.2%
EBITDA · FY 2025
₹4.49 Cr margin 11.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 6%
5 years · compounded
▲ 32%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 53%
5 years · compounded
▲ 60%
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.4% | ||||
| Net Profit Margin | 5.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jo Pharma Limited, buy the company report.
Board of directors of Jo Pharma Limited
Jo Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakshit Jindal Also directs: Jindal-Sungshin India Co. Private Limited, Jindal Kim Ventures Private Limited, Hindustan Green Energy Limited and 5 more | Director | 12 Dec 2015 | 10 Years 10 Months | Current |
| Ankit Jindal Also directs: Jindal-Sungshin India Co. Private Limited, Hindustan Green Energy Limited, Hindustan Tapes Private Limited and 5 more | Director | 12 Dec 2015 | 10 Years 10 Months | Current |
| Suresh Baid Also directs: Amigos Buildwell LLP, Coast to Coast Designs Limited, Donyi Polo Timbers Private Limited. and 5 more | Director | 22 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Jo Pharma Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (textile, leather and other apparel products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MMC Health Care Limited | ₹39.6 Cr (FY 2024) | -17.0% | Chennai, Tamil Nadu, India | |||
| Strides Emerging Markets Limited | ₹39.32 Cr (FY 2020) | 735.0% | Bangalore, Karnataka, India | |||
| Giyaan Pharma Private Limited | ₹39.31 Cr (FY 2024) | 16.0% | Hyderabad, Telangana, India | |||
| Embiotic Laboratories Private Limited | ₹39.29 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Forma Chem Pvt Ltd | ₹39.25 Cr (FY 2025) | -46.0% | Kolkata, West Bengal, India | |||
| Jo Pharma Limitedthis company | ₹39.24 Cr (FY 2025) | ₹2.05 Cr | 5.2% | -10.0% | Delhi, India | |
| Civentichem (India) Private Limited | ₹39.15 Cr (FY 2024) | -52.0% | Hyderabad, Telangana, India | |||
| Bion Therapeutics (India) Private Limited | ₹38.99 Cr (FY 2024) | 4.0% | Hyderabad, Telangana, India | |||
| Allegro Speciality Chemicals Private Limited | ₹38.95 Cr (FY 2025) | -21.0% | Hyderabad, Telangana, India | |||
| Sigma Laboratories Private Limited | ₹38.91 Cr (FY 2025) | -26.0% | Mumbai, Maharashtra, India | |||
| Revinto Life Science Private Limited | ₹38.71 Cr (FY 2024) | 44.0% | Karwar, Karnataka, India |
To see the full peer comparison of Jo Pharma Limited, buy the company report.
Auditor
Jo Pharma Limited is audited by ABNG & Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABNG & Company | FY 2023 | 027223N |
Shareholding
The shareholding of Jo Pharma Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jo Pharma Limited, buy the company report.
Charges & borrowings
Open charges
₹13.76 Cr
Satisfied charges
₹9.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Mar 2025 | 101101664 | Axis Bank Limited | ₹1.8 Cr | Open | |
| 28 Sep 2023 | 100788171 | Others | ₹11.65 Cr | Open | |
| 19 Nov 2019 | 100322191 | Axis Bank Limited | ₹31 Lakh | Open | |
| 19 Aug 2022 | 100609454 | Others | ₹5 Cr | Satisfied | |
| 26 Apr 2022 | 100593834 | Axis Bank Limited | ₹45.57 Lakh | Satisfied |
To see the full charge records of Jo Pharma Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Jo Pharma Limited has 12 court cases on record: 11 filed by Jo Pharma, 1 filed against it. 4 cases are pending and 8 are disposed.
Total cases
12
Filed by the company
11
Filed against the company
1
Pending
4
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 1 | 4 |
| High courts | 4 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South, Delhi | Commercial suit | Filed by the company against Hema and Vidhi Enterprises | Pending |
| District court, South, Delhi | Civil suit | Filed by the company against individuals | Pending |
| District court, Shimla, Himachal Pradesh | Arbitration matter | Filed by the company against M/S Protect Telelinks | Pending |
| District court, Shimla, Himachal Pradesh | Civil miscellaneous application | Filed by the company against M/S Protect Telelinks | Pending |
| District court, South, Delhi | Interim or miscellaneous application | Filed by the company against an individual | Disposed |
To see the full case history of Jo Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jo Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jo Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCJ6242K1ZF | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jo Pharma Limited, buy the company report.
Recent activity
Jo Pharma Limited has 6 board changes on record since 2015: 3 appointments and 3 cessations. The latest: Suresh Baid ceased to be Additional Director on 29 Sep 2024.
AGM
Jo Pharma Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Jo Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 26 Apr 2022 via Charge ID 100593834 with Axis Bank Limited was fully satisfied on 26 Mar 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.80 Cr with Charge ID 101101664 was registered on 18 Mar 2025.
Ceased
Suresh Baid ceased to be Additional Director.
Appointed
Suresh Baid was appointed as Director.
Charges
A charge with Others amounted to Rs. 11.65 Cr with Charge ID 100788171 was registered on 28 Sep 2023.
Charges
A charge registered on 19 Aug 2022 via Charge ID 100609454 with Others was fully satisfied on 14 Sep 2023.
Charges
A charge registered on 30 Nov 2018 via Charge ID 100232657 with Others was fully satisfied on 15 Sep 2022.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100609454 was registered on 19 Aug 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.46 Cr with Charge ID 100593834 was registered on 26 Apr 2022.
Ceased
Shakun Jindal ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Jo Pharma is an active public limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 12 December 2015 (11+ years old) and is registered under CIN U23109DL2015PLC288456.
Jo Pharma has 3 current directors:
- Rakshit Jindal - Director
- Ankit Jindal - Director
- Suresh Baid - Director
The latest financial statements of Jo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Jo Pharma is 07AADCJ6242K1ZF, registered in Delhi.
The CIN (Corporate Identification Number) of Jo Pharma is U23109DL2015PLC288456. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jo Pharma has 12 court cases on record: 11 filed by the company and 1 filed against it. 4 are pending. Most are in the district courts.
Jo Pharma was incorporated on 12 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jo Pharma by revenue are MMC Health Care Limited, Strides Emerging Markets Limited, Giyaan Pharma Private Limited, Embiotic Laboratories Private Limited, Forma Chem Pvt Ltd and 5 more, all in the Pharma industry (Formulations), with the same principal business activity (textile, leather and other apparel products).
Suresh Baid ceased to be Additional Director on 29 Sep 2024. Suresh Baid was appointed as Director on 22 Aug 2024. Shakun Jindal ceased to be Director on 10 Jan 2022. Jo Pharma has 6 board changes on record in total.
Yes, Jo Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-10-0012312).
Jo Pharma can be reached through the website jopharma.com. Its registered office is in Delhi, India.